US EditionAtriCure (NASDAQ:ATRC) Raised to “Buy” at Wall Street Zen
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
AtriCure (NASDAQ:ATRC) Raised to “Buy” at Wall Street Zen
Wall Street Zen upgraded shares of AtriCure (NASDAQ:ATRC – Free Report) from a hold rating to a buy rating in a research report report published on Saturday morning. Other equities analysts also recently issued reports about the company. Needham & Company LLC decreased their target price on AtriCure from $51.00 to $44.00 and set a […]
AtriCure (NASDAQ:ATRC) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of AtriCure (NASDAQ:ATRC – Free Report) from a hold rating to a buy rating in a research report sent to investors on Saturday morning. ATRC has been the subject of a number of other reports. JMP Securities reissued a “market outperform” rating and set a $60.00 price target on shares […]
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
